271 related articles for article (PubMed ID: 32123902)
1. The acute myeloid leukemia variant DNMT3A Arg882His is a DNMT3B-like enzyme.
Norvil AB; AlAbdi L; Liu B; Tu YH; Forstoffer NE; Michie AR; Chen T; Gowher H
Nucleic Acids Res; 2020 Apr; 48(7):3761-3775. PubMed ID: 32123902
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation.
Kosaki R; Terashima H; Kubota M; Kosaki K
Am J Med Genet A; 2017 Jan; 173(1):250-253. PubMed ID: 27991732
[TBL] [Abstract][Full Text] [Related]
3. CpG sites preferentially methylated by Dnmt3a in vivo.
Oka M; Rodić N; Graddy J; Chang LJ; Terada N
J Biol Chem; 2006 Apr; 281(15):9901-8. PubMed ID: 16439359
[TBL] [Abstract][Full Text] [Related]
4. Dnmt3b Methylates DNA by a Noncooperative Mechanism, and Its Activity Is Unaffected by Manipulations at the Predicted Dimer Interface.
Norvil AB; Petell CJ; Alabdi L; Wu L; Rossie S; Gowher H
Biochemistry; 2018 Jul; 57(29):4312-4324. PubMed ID: 27768276
[TBL] [Abstract][Full Text] [Related]
5. Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns.
Emperle M; Adam S; Kunert S; Dukatz M; Baude A; Plass C; Rathert P; Bashtrykov P; Jeltsch A
Nucleic Acids Res; 2019 Dec; 47(21):11355-11367. PubMed ID: 31620784
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA Methylation Signatures Are Determined by DNMT3A/B Sequence Preferences.
Mao SQ; Cuesta SM; Tannahill D; Balasubramanian S
Biochemistry; 2020 Jul; 59(27):2541-2550. PubMed ID: 32543182
[TBL] [Abstract][Full Text] [Related]
7. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive structure-function characterization of DNMT3B and DNMT3A reveals distinctive de novo DNA methylation mechanisms.
Gao L; Emperle M; Guo Y; Grimm SA; Ren W; Adam S; Uryu H; Zhang ZM; Chen D; Yin J; Dukatz M; Anteneh H; Jurkowska RZ; Lu J; Wang Y; Bashtrykov P; Wade PA; Wang GG; Jeltsch A; Song J
Nat Commun; 2020 Jul; 11(1):3355. PubMed ID: 32620778
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
[TBL] [Abstract][Full Text] [Related]
10. A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells.
Kim SJ; Zhao H; Hardikar S; Singh AK; Goodell MA; Chen T
Blood; 2013 Dec; 122(25):4086-9. PubMed ID: 24167195
[TBL] [Abstract][Full Text] [Related]
11. Flanking sequence preference modulates de novo DNA methylation in the mouse genome.
Mallona I; Ilie IM; Karemaker ID; Butz S; Manzo M; Caflisch A; Baubec T
Nucleic Acids Res; 2021 Jan; 49(1):145-157. PubMed ID: 33290556
[TBL] [Abstract][Full Text] [Related]
12. Murine de novo methyltransferase Dnmt3a demonstrates strand asymmetry and site preference in the methylation of DNA in vitro.
Lin IG; Han L; Taghva A; O'Brien LE; Hsieh CL
Mol Cell Biol; 2002 Feb; 22(3):704-23. PubMed ID: 11784849
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.
Lu R; Wang P; Parton T; Zhou Y; Chrysovergis K; Rockowitz S; Chen WY; Abdel-Wahab O; Wade PA; Zheng D; Wang GG
Cancer Cell; 2016 Jul; 30(1):92-107. PubMed ID: 27344947
[TBL] [Abstract][Full Text] [Related]
14. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation.
Dodge JE; Ramsahoye BH; Wo ZG; Okano M; Li E
Gene; 2002 May; 289(1-2):41-8. PubMed ID: 12036582
[TBL] [Abstract][Full Text] [Related]
15. Dissect the DNMT3A- and DNMT3B-mediated DNA Co-methylation through a Covalent Complex Approach.
Gao L; Anteneh H; Song J
J Mol Biol; 2020 Jan; 432(2):569-575. PubMed ID: 31726062
[TBL] [Abstract][Full Text] [Related]
16. The DNMT3A R882H mutant displays altered flanking sequence preferences.
Emperle M; Rajavelu A; Kunert S; Arimondo PB; Reinhardt R; Jurkowska RZ; Jeltsch A
Nucleic Acids Res; 2018 Apr; 46(6):3130-3139. PubMed ID: 29518238
[TBL] [Abstract][Full Text] [Related]
17. Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells.
Bera R; Chiu MC; Huang YJ; Liang DC; Lee YS; Shih LY
Neoplasia; 2018 Nov; 20(11):1106-1120. PubMed ID: 30245403
[TBL] [Abstract][Full Text] [Related]
18. Structure-guided functional suppression of AML-associated DNMT3A hotspot mutations.
Lu J; Guo Y; Yin J; Chen J; Wang Y; Wang GG; Song J
Nat Commun; 2024 Apr; 15(1):3111. PubMed ID: 38600075
[TBL] [Abstract][Full Text] [Related]
19. The methyltransferase domain of DNMT1 is an essential domain in acute myeloid leukemia independent of DNMT3A mutation.
Bhogal B; Weir BA; Crescenzo R; Marien A; Kwon MC; Philippar U; Cowley GS
Commun Biol; 2022 Nov; 5(1):1174. PubMed ID: 36329185
[TBL] [Abstract][Full Text] [Related]
20. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b.
Hsieh CL
Mol Cell Biol; 1999 Dec; 19(12):8211-8. PubMed ID: 10567546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
